Cost-effectiveness analysis of prostate cancer screening and MRI

World J Urol. 2024 Apr 5;42(1):212. doi: 10.1007/s00345-024-04943-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biopsy
  • Cost-Effectiveness Analysis
  • Early Detection of Cancer / economics
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Prostate-Specific Antigen
  • Prostatic Hyperplasia*
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / epidemiology

Substances

  • Prostate-Specific Antigen